Clinical Trials on Inherited Arrhythmias and Valvulopathies in India

Total 105 results

Medtronic Bakken Research Center

Completed

PANORAMA Observational Study

Heart Failure | Heart Block | Arrhythmia | Sinus Node Disease

Belgium, Russian Federation, Former Serbia and Montenegro, India, Kuwait, Saudi Arabia
Christian Medical College, Vellore, India
Dr. H. Trent Spencer, Professor, Emory University of Medicine, Atlanta Ga...

Recruiting

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

Hemophilia A

India
The Cleveland Clinic

Terminated

Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery

Atrial Fibrillation

India
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

RIXUBIS PMS India (RIXUBIS PMS)

Hemophilia B

India
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia

Arrhythmias

Denmark, United States, Italy, Brazil, Russian Federation, Canada, Serbia, United Kingdom, Romania, Ukraine, India, Sweden, Mexico, Croatia, Hungary, Poland
Icahn School of Medicine at Mount Sinai
Biosense Webster, Inc.

Terminated

INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events (INTERVENE)

Ventricular Tachycardia

India
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Sintesi Research Srl

Unknown

Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients (ITI)

Hemophilia A

India, Egypt
Bayer
Janssen Research & Development, LLC

Active, not recruiting

A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF) (XARIN)

Non-valvular Atrial Fibrillation (NVAF)

India
Medtronic Cardiac Rhythm and Heart Failure

Completed

Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady) (IMPROVE Brady)

Sinus Node Dysfunction

Peru, Bangladesh, India, Mexico, Argentina, Russian Federation, Uruguay
Baxalta now part of Shire
Takeda Development Center Americas, Inc.

Completed

A Study of ADVATE in People With Hemophilia A in India

Hemophilia A

India
Pfizer

Completed

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients

Hemophilia A

India
Pfizer

Completed

Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B

Hemophilia B

India
Abbott Medical Devices

Completed

Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (SJM) Cardiac Rhythm Management Systems (ASSUREMRI)

Bradycardia | Tachycardia

Australia, India
Abbott Medical Devices

Active, not recruiting

LBBAP Data Collection Registry

Heart Failure | Heart Block | Bradycardia | Syncope | Cardiomyopathies | Sinus Node Dysfunction

United States, Singapore, France, India, Italy
Octapharma

Completed

Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency

Congenital Fibrinogen Deficiency

India, Iran, Islamic Republic of, Lebanon
Abbott Medical Devices

Completed

ENHANCE-Efficacy of the Presence of Right Ventricular Apical Pacing Induced Ventricular Dyssynchrony as a Guiding Parameter for Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction (ENHANCE)

Bradycardia

Thailand, China, Australia, India, Italy
Duke University
Bristol-Myers Squibb; Bayer; Boehringer Ingelheim; Daiichi Sankyo, Inc.

Completed

Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation (IMPACT-AF)

Atrial Fibrillation

China, Brazil, Argentina, India, Romania
Biotronik SE & Co. KG

Terminated

Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease (B3)

Sinus Node Disease

Spain, Hungary, Taiwan, Korea, Republic of, India, Singapore, Italy, China, Malaysia
Abbott Medical Devices

Completed

Accent Cardiac MRI Study (Accent Cardiac)

Bradycardia

Thailand, Hong Kong, Malaysia, India, China
Grifols Therapeutics LLC
Instituto Grifols, S.A.

Completed

Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia (IG0902)

Congenital Afibrinogenemia

India, United States, Italy, Lebanon
Abbott Medical Devices

Completed

Abbott Brady 3T MRI PMCF

Fatigue | Bradycardia | Syncope | Arrythmia | Presyncope | Disorientation

Netherlands, Estonia, France, India, Italy
Bayer
Janssen Research & Development, LLC

Completed

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia (XANAP)

Atrial Fibrillation

Indonesia, Korea, Republic of, Malaysia, Singapore, Thailand, Philippines, Taiwan, Hong Kong, India, Pakistan, Vietnam
Novo Nordisk A/S

Completed

Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (HAEMOcare)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

India, Morocco, South Africa, Oman
Medexus Pharma, Inc.

Terminated

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

Hemophilia B

United States, United Kingdom, India
Medtronic Cardiac Rhythm and Heart Failure

Active, not recruiting

Management of Device Detected AT and Impact of Device Treatment Algorithms on Atrial Fibrillation (MANDATE-AF)

Cardiovascular Diseases

India
Instituto Grifols, S.A.

Withdrawn

FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis

Hypofibrinogenemia | Congenital Afibrinogenemia

India, Turkey, Lebanon, United States, Bulgaria
Abbott Medical Devices

Completed

A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging (ASIA MRI ICD)

Tachycardia | ICD

Korea, Republic of, India, Malaysia
Baxalta now part of Shire

Completed

BAX 326 Pediatric Study

Hemophilia B

Russian Federation, Ukraine, India, Poland, Romania, United Kingdom
Octapharma

Completed

Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

Congenital Fibrinogen Deficiency | Afibrinogenemia

Iran, Islamic Republic of, United States, Bulgaria, India, Switzerland, United Kingdom
Genzyme, a Sanofi Company

Active, not recruiting

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B (ATLAS-PEDS)

Hemophilia

Canada, Italy, Turkey, Spain, United States, India
Christian Medical College, Vellore, India

Unknown

Musculoskeletal Function in Hemophilia

Hemophilia

India, Argentina, Brazil, Egypt, Iran, Islamic Republic of, Singapore, South Africa, Thailand, Venezuela
Octapharma

Completed

Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

Severe Hemophilia A

United States, France, Canada, United Kingdom, India, Georgia, Moldova, Republic of, Poland, Ukraine
Octapharma

Completed

Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery

Congenital Fibrinogen Deficiency

United States, Bulgaria, India, Iran, Islamic Republic of, Lebanon, Russian Federation, Saudi Arabia, Turkey, United Kingdom
Novo Nordisk A/S

Completed

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period (guardian 10)

Congenital Bleeding Disorder | Haemophilia A

India
Baxalta now part of Shire

Completed

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

Acquired Hemophilia A

United States, Canada, India, United Kingdom
Sheri Kashmir Institute of Medical Sciences
University of Pennsylvania; Indian Heart Rhythm Society; Sri Jayadeva Institute...

Active, not recruiting

South Asian Arrhythmogenic Cardiomyopathy Registry

Ventricular Tachycardia | Sudden Cardiac Death | Arrhythmogenic Right Ventricular Cardiomyopathy | Arrhythmogenic Right Ventricular Dysplasia | Arrhythmogenic Ventricular Cardiomyopathy | Arrhythmogenic Cardiomyopathy

United States, India
Astellas Pharma Inc
Astellas Pharma US, Inc.; Advanz Pharma

Completed

Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery

Atrial Fibrillation | Atrial Flutter

Poland, United States, Canada, Argentina, Denmark, India
Abbott Medical Devices

Active, not recruiting

Confirm Rx Insertable Cardiac Monitor SMART Registry

Atrial Fibrillation | Cardiac Arrhythmias | Symptoms and Signs

Korea, Republic of, Canada, Netherlands, Belgium, United States, United Kingdom, Germany, Latvia, Argentina, Spain, Italy, Saudi Arabia, Japan, Portugal, South Africa, India, Slovakia, Austria, Algeria, Hungary, Israel, Kuwait, Puerto...
Octapharma

Completed

Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery (WONDERS)

Prevent Bleeding in Major Surgery

United States, Turkey, Romania, India, Bulgaria, Italy, Oman, Poland, South Africa
Abbott Medical Devices

Completed

Physiologic Pacing Registry

Heart Failure | Heart Block | Bradycardia | Syncope | Cardiomyopathies | Ventricular Tachycardia | Sinus Node Dysfunction

United States, Australia, Netherlands, South Africa, Switzerland, Spain, Germany, Singapore, Canada, Austria, Czechia, France, Hong Kong, India, Italy, Poland
Kansas City Heart Rhythm Institute
Kansas City Heart Rhythm Research Foundation

Completed

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation (STROKE-VT)

Stroke | Ventricular Tachycardia | Premature Ventricular Contraction

United States, India
Grifols Therapeutics LLC
Grifols Biologicals, LLC

Terminated

Alphanate in Immune Tolerance Induction Therapy

Hemophilia A, Congenital

United States, Spain, Italy, India, Canada, Russian Federation
Medexus Pharma, Inc.

Completed

Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B

Hemophilia B

United States, France, United Kingdom, India, Israel, Italy, Poland
University Hospital, Geneva

Completed

Quality of Life in Patients With Congenital Afibrinogenemia (QualyAFIB)

Afibrinogenemia, Congenital

France, Turkey, Switzerland, Netherlands, Spain, India, Poland, Canada, United States, Algeria, Egypt, Germany, Italy, Japan, Kuwait, Lebanon, Morocco, Pakistan, Serbia, Slovakia, Tunisia
Abbott Medical Devices

Recruiting

EP Device Registry

Cardiac Rhythm Disorder

India, Netherlands, Czechia, France, Germany, Hungary, Italy, Portugal, Spain, Austria
Boston Scientific Corporation
University of Rochester

Terminated

MADIT ASIA Cardiac Resynchronization Trial (MADIT-ASIA)

Congestive Heart Failure | Heart Failure, Systolic | Left Bundle Branch Block

Singapore, Japan, Malaysia, Korea, Republic of, Taiwan, China, India, Thailand
Baxalta now part of Shire

Completed

BAX 326 (rFIX) Continuation Study

Hemophilia B

Taiwan, Colombia, Argentina, Brazil, Bulgaria, Chile, Czechia, India, Ireland, Italy, Japan, Poland, Romania, Russian Federation, Sweden, Ukraine, United Kingdom
Catalyst Biosciences

Terminated

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

Factor VII Deficiency | Hemophilia A With Inhibitor | Glanzmann Thrombasthenia

United States, India, Italy, Russian Federation, Ukraine
Fondazione Angelo Bianchi Bonomi
Sintesi Research Srl

Completed

Survey of Inhibitors in Plasma-Product Exposed Toddlers (SIPPET)

Hemophilia A

United States, India, Spain, Argentina, Austria, Brazil, Chile, Egypt, Iran, Islamic Republic of, Italy, Mexico, Saudi Arabia, South Africa, Turkey
Octapharma

Completed

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

Severe Hemophilia A

Canada, United States, France, Spain, Ukraine, United Kingdom, Belarus, Georgia, Germany, India, Italy, Moldova, Republic of, Morocco, Poland, Portugal, Russian Federation, Slovenia

Clinical Trials on Inherited Arrhythmias and Valvulopathies in India

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations